Leading science, pioneering therapies

CRM Publications

Found 41 results
Filters: Keyword is Animals, Genetically Modified  [Clear All Filters]
2014
Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, Kiskinis E, Winborn B, Freibaum BD, Kanagaraj A et al..  2014.  Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.Neuron. 81(3):536-43.
Grygoruk A, Chen A, Martin CA, Lawal HO, Fei H, Gutierrez G, Biedermann T, Najibi R, Hadi R, Chouhan AK et al..  2014.  The redistribution of Drosophila vesicular monoamine transporter mutants from synaptic vesicles to large dense-core vesicles impairs amine-dependent behaviors.J Neurosci. 34(20):6924-37.
2013
Rossano AJ, Chouhan AK, Macleod GT.  2013.  Genetically encoded pH-indicators reveal activity-dependent cytosolic acidification of Drosophila motor nerve termini in vivo.J Physiol. 591(7):1691-706.
Czopka T, ffrench-Constant C, Lyons DA.  2013.  Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.Dev Cell. 25(6):599-609.
2012
Münzel EJolanda, Schaefer K, Obirei B, Kremmer E, Burton EA, Kuscha V, Becker CG, Brösamle C, Williams AC, Becker T.  2012.  Claudin k is specifically expressed in cells that form myelin during development of the nervous system and regeneration of the optic nerve in adult zebrafish.Glia. 60(2):253-70.
Chouhan AK, Ivannikov MV, Lu Z, Sugimori M, Llinas RR, Macleod GT.  2012.  Cytosolic calcium coordinates mitochondrial energy metabolism with presynaptic activity.J Neurosci. 32(4):1233-43.
2011
Almeida RG, Czopka T, ffrench-Constant C, Lyons DA.  2011.  Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.Development. 138(20):4443-50.
2010
Meek S, Buehr M, Sutherland L, Thomson AJ, Mullins JJ, Smith AG, Burdon T.  2010.  Efficient gene targeting by homologous recombination in rat embryonic stem cells.PLoS One. 5(12):e14225.
2008
McGrew MJ, Sherman A, Lillico SG, Ellard FM, Radcliffe PA, Gilhooley HJ, Mitrophanous KA, Cambray N, Wilson V, Sang HM.  2008.  Localised axial progenitor cell populations in the avian tail bud are not committed to a posterior Hox identity.Development. 135(13):2289-99.
2003
Buehr M, Nichols J, Stenhouse FH, Mountford P, Greenhalgh CJ, Kantachuvesiri S, Brooker G, Mullins JJ, Smith AG.  2003.  Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines.Biol Reprod. 68(1):222-9.
1999
Brosnan MJ, Devlin AM, Clark JS, Mullins JJ, Dominiczak AF.  1999.  Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27.Am J Hypertens. 12(7):724-31.
Jacinto SM, Mullins JJ, Mitchell KD.  1999.  Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats.Am J Physiol. 276(2 Pt 2):F315-22.
1998
Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ, McEwan JR.  1998.  Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27.J Hypertens. 16(5):635-43.
Wolf CR, Campbell SJ, Clark AJ, Smith A, Bishop JO, Henderson CJ.  1998.  The use of transgenic animals to assess the role of metabolism in target organ toxicity.Arch Toxicol Suppl. 20:443-53.
1997
Sharp MG, Kantachuvesiri S, Mullins JJ.  1997.  Genotype and cardiovascular phenotype: lessons from genetically manipulated animals and diseased humans.Curr Opin Nephrol Hypertens. 6(1):51-7.
Mitchell KD, Jacinto SM, Mullins JJ.  1997.  Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.Am J Physiol. 273(2 Pt 2):F246-53.
1996
Mullins LJ, Mullins JJ.  1996.  Transgenesis in the rat and larger mammals.J Clin Invest. 97(7):1557-60.
Mullins LJ, Morley SD, Mullins JJ.  1996.  Transgenics and essential hypertension.J Hum Hypertens. 10(10):627-31.
Véniant M, Ménard J, Bruneval P, Morley S, Gonzales MF, Mullins JJ.  1996.  Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.J Clin Invest. 98(9):1966-70.
1995
Morley SD, Viard I, Parker KL, Mullins JJ.  1995.  Adrenal-specific transgene expression and derivation of conditionally immortal rat adrenocortical cell lines.Endocr Res. 21(1-2):353-7.
Mitchell KD, Mullins JJ.  1995.  ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats.Am J Physiol. 268(5 Pt 2):F821-8.
Véniant M, Whitworth CE, Ménard J, Sharp MG, Gonzales MF, Bruneval P, Mullins JJ.  1995.  Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats.Am J Hypertens. 8(12 Pt 1):1167-76.
Whitworth CE, Fleming S, Kotelevtsev Y, Manson L, Brooker GA, Cumming AD, Mullins JJ.  1995.  A genetic model of malignant phase hypertension in rats.Kidney Int. 47(2):529-35.
Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T.  1995.  Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.Br J Pharmacol. 116(4):2237-44.

Pages